EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Proteomic and scRNA‐Seq Analysis Reveals Pyroptosis‐Related Subtypes in Lung Adenocarcinoma

Tianchang Wei, Yongqi Wei, Weiqi Mao, Cuiping Zhang, Jian Xu iD, Chunlai Lu, Yuanlin Song, Xiaoyan Chen

The Clinical Respiratory Journal · 2026-07 · 20 (7)

DOI: 10.1111/crj.70210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 05.07.2026. Verfasst von Tianchang Wei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Shanghai Key Laboratory of Lung Inflammation and Injury, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Proteomics, Pyroptosis, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project, Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pyroptosis is a recently identified form of programmed cell death that plays an important role in cancer initiation and progression. However, the function of pyroptosis in lung adenocarcinoma (LUAD) remains unclear. The study integrated proteomic and single‐cell RNA sequence (scRNA‐seq) data to investigate the potential role of pyroptosis‐related proteins (PRPs) in the tumor microenvironment (TME) and their associations with tumor immunity, prognosis, and therapeutic response.

Methods

A comprehensive proteomic analysis was conducted on 103 lung adenocarcinoma patients. We integrated scRNA‐seq data with bioinformatics analyses to evaluate prognostic and immunological characteristics. Unsupervised clustering based on the PRP expression identified three subtypes. We then used gene set enrichment analysis (GSEA) to assess biological functions. We applied TME and CIBERSORT algorithms to analyze immune cell infiltration. Next, we performed functional enrichment, immune infiltration, and cell–cell communication analyses using scRNA‐seq data grouped according to the proteomic subtypes. We constructed a PRP‐related prognostic signature using least absolute shrinkage and selection operator (LASSO)‐Cox regression analysis. Finally, we validated the expression and functional significance of selected proteins by immunohistochemistry, Western blotting, quantitative PCR, and in vitro loss‐of‐function assays.

Results

We identified multiple PRPs that correlated with clinicopathologic characteristics, patient prognosis, and immune infiltration patterns in the TME. We further identified three distinct molecular subtypes, including lipid metabolism, signaling transduction, and immune activation. Among these subtypes, the lipid metabolism subtype showed the best prognosis. ScRNA‐seq analysis further supported the immune characteristics of three subtypes and revealed distinct cellular interaction networks and ligand‐receptor pairs. We also established and validated a PRP‐related prognostic score that effectively predicted overall survival in patients with LUAD. In addition, the PRP score was significantly associated with tumor immune status and sensitivity to chemotherapeutic agents.

Conclusion

Our integrated analysis of proteomic and scRNA‐seq data demonstrated that PRPs are closely associated with the tumor‐immune‐stromal microenvironment, clinicopathological features, and prognosis in LUAD. These findings improve our understanding of the biological roles of PRPs in LUAD and may provide new strategies for prognostic evaluation and immunotherapy development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsPyroptosisLung NeoplasmsAdenocarcinoma of LungRNA-SeqHumansPrognosisTumor MicroenvironmentFemaleMaleMiddle AgedSingle-Cell Gene Expression Analysis

Stichwörter der Autor:innen

lung adenocarcinomaprognosis immune signaturespyroptosis

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Shanghai Key Laboratory of Lung Inflammation and Injury, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shanghai Institute of Infectious Disease and Biosecurity, Shanghai, China.
  • Shanghai Respiratory Research Institute, Shanghai, China.
  • Key Laboratory of Chemical Injury, Emergency and Critical Medicine of Shanghai Municipal Health Commission, Center of Emergency and Critical Medicine, Jinshan Hospital of Fudan University, Shanghai, China.

ORCID-Profile: Jian Xu

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Science and Technology Major Project
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • R&D Program of Guangzhou National Laboratory
  • Zhongshan Hospital, Fudan University
  • China Postdoctoral Science Foundation
  • Outstanding Resident Clinical Postdoctoral Program of Zhongshan Hospital Affiliated to Fudan University
  • Zhongshan Hospital

Zitieren

APA

Wei, T., Wei, Y., Mao, W., Zhang, C., Xu, J., Lu, C., Song, Y., & Chen, X. (2026). Integrated Proteomic and scRNA‐Seq Analysis Reveals Pyroptosis‐Related Subtypes in Lung Adenocarcinoma. The Clinical Respiratory Journal, 20(7). https://doi.org/10.1111/crj.70210

Vancouver

Wei T, Wei Y, Mao W, Zhang C, Xu J, Lu C, et al. Integrated Proteomic and scRNA‐Seq Analysis Reveals Pyroptosis‐Related Subtypes in Lung Adenocarcinoma. The Clinical Respiratory Journal. 2026;20(7). doi:10.1111/crj.70210

BibTeX
@article{Wei2026,
  author = {Wei, Tianchang and Wei, Yongqi and Mao, Weiqi and Zhang, Cuiping and Xu, Jian and Lu, Chunlai and Song, Yuanlin and Chen, Xiaoyan},
  title = {Integrated Proteomic and scRNA‐Seq Analysis Reveals Pyroptosis‐Related Subtypes in Lung Adenocarcinoma},
  journal = {The Clinical Respiratory Journal},
  year = {2026},
  volume = {20},
  number = {7},
  doi = {10.1111/crj.70210}
}
Kostenlos starten →